Remove 2024 Remove Innovation Remove Pharmacology
article thumbnail

Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device?

DAIC

Getty Images milla1cf Tue, 02/27/2024 - 17:24 February 27, 2024 — Biosense Webster, Inc. , Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrial fibrillation (NVAF) treatment. Jennifer Currin, Ph.D., The acquisition of Laminar, Inc.

article thumbnail

Top Interventional Cardiology Conferences and Courses in 2024

Cardiology Update

Here is our curated list of the top interventional cardiology conferences and courses scheduled for 2024. Additionally, be sure to review the main general cardiology conferences listed in our Top 10 Cardiology Conferences for 2024. Noncoronary topics like structural heart disease and vascular medicine are also addressed.

article thumbnail

Embedding innovation in clinical practice to improve patient care across cardiovascular disease

The British Journal of Cardiology

Faculty member Affiliation Professor Amitava Banerjee Professor of Clinical Data Science, Institute of Health Informatics, University College London; Consultant Cardiologist, University College London Hospitals and Barts Health NHS Trust Professor Sir Mark Caulfield Professor of Clinical Pharmacology, Queen Mary Un.

article thumbnail

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

DAIC

April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, The “Pharmacology Program” will cover hot topics in cardiovascular medicine that are key issues that pharmacists, as well as other health care team members, face in managing complex patients. Notably, 2024 marks the 40th Anniversary of ACC/AHA Guidelines.

Education 105
article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

The 19th Annual CMHC transformed Boston into the epicenter of cardiometabolic health and risk reduction from October 17-19, 2024, bringing together healthcare professionals from around the globe for the largest event of its kind in the US. Aronne, MD , discussed advances in obesity pharmacology, while Virend K. Ballantyne, MD.

CME 64
article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

Image courtesy: ACC christine.book Thu, 02/29/2024 - 11:22 February 29, 2024 — The American College of Cardiology ( ACC ) will soon be holding its ACC 73rd Annual Scientific Session & Expo , ACC.24 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center. The Guidelines Sessions at ACC.24

article thumbnail

Abstract 4140419: Targeting Cardiac Fibrosis with Chimeric Antigen Receptor Neutrophils from Human Pluripotent Stem Cells

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4140419-A4140419, November 12, 2024. Current treatments, predominantly pharmacological, target signaling pathways involved in fibroblast activation but often come with side effects such as cardiac toxicities.